Literature DB >> 17035520

Addiction and arousal: alternative roles of hypothalamic peptides.

Luis de Lecea1, Barbara E Jones, Benjamin Boutrel, Stephanie L Borgland, Seiji Nishino, Michael Bubser, Ralph DiLeone.   

Abstract

The importance of the lateral hypothalamus in the regulation of reward and motivation has long been recognized. However, the neuronal network involved in such a hypothalamic regulation of reward remains essentially unknown. Recently, hypocretin-containing neurons, a group of hypothalamic neurons known to be associated with the stability of arousal, have emerged as important structures in the control of brain reward function. This review summarizes a Mini-Symposium presented at the 2006 Annual Meeting of the Society for Neuroscience.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035520      PMCID: PMC6674693          DOI: 10.1523/JNEUROSCI.3118-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons.

Authors:  M A Ungless; J L Whistler; R C Malenka; A Bonci
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

2.  State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking.

Authors:  Y Koyama; K Takahashi; T Kodama; Y Kayama
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

3.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

4.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

5.  CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.

Authors:  D J Macey; G F Koob; A Markou
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

6.  Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area.

Authors:  J Fadel; A Y Deutch
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area.

Authors:  Md Noor Alam; Hui Gong; Tarannum Alam; Rajesh Jaganath; Dennis McGinty; Ronald Szymusiak
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

8.  Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.

Authors:  Raphaëlle Winsky-Sommerer; Akihiro Yamanaka; Sabrina Diano; Erzsebet Borok; Amanda J Roberts; Takeshi Sakurai; Thomas S Kilduff; Tamas L Horvath; Luis de Lecea
Journal:  J Neurosci       Date:  2004-12-15       Impact factor: 6.167

9.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

10.  Hypocretin/Orexin excites hypocretin neurons via a local glutamate neuron-A potential mechanism for orchestrating the hypothalamic arousal system.

Authors:  Ying Li; Xiao Bing Gao; Takeshi Sakurai; Anthony N van den Pol
Journal:  Neuron       Date:  2002-12-19       Impact factor: 17.173

View more
  37 in total

1.  Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA.

Authors:  Mark G LeSage; Jennifer L Perry; Catherine M Kotz; David Shelley; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2010-02-24       Impact factor: 4.530

2.  Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels.

Authors:  Anne Venner; Mahesh M Karnani; J Antonio Gonzalez; Lise T Jensen; Lars Fugger; Denis Burdakov
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

Review 3.  K+ channels stimulated by glucose: a new energy-sensing pathway.

Authors:  Denis Burdakov
Journal:  Pflugers Arch       Date:  2007-01-06       Impact factor: 3.657

Review 4.  Stress and disease: is being female a predisposing factor?

Authors:  Jill B Becker; Lisa M Monteggia; Tara S Perrot-Sinal; Russell D Romeo; Jane R Taylor; Rachel Yehuda; Tracy L Bale
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

5.  Role of lateral hypothalamus in two aspects of attention in associative learning.

Authors:  Daniel S Wheeler; Sandy Wan; Alexandra Miller; Nicole Angeli; Bayan Adileh; Weidong Hu; Peter C Holland
Journal:  Eur J Neurosci       Date:  2014-04-21       Impact factor: 3.386

6.  Dichotomous cellular properties of mouse orexin/hypocretin neurons.

Authors:  Cornelia Schöne; Anne Venner; David Knowles; Mahesh M Karnani; Denis Burdakov
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

Review 7.  Arousal and drug abuse.

Authors:  Francisco J Urbano; Verónica Bisagno; Edgar Garcia-Rill
Journal:  Behav Brain Res       Date:  2017-07-17       Impact factor: 3.332

8.  [Relationships between sleep and addiction].

Authors:  Francesca Cañellas; Luis de Lecea
Journal:  Adicciones       Date:  2012       Impact factor: 2.979

Review 9.  Dissociation between sensing and metabolism of glucose in sugar sensing neurones.

Authors:  J Antonio Gonzàlez; Frank Reimann; Denis Burdakov
Journal:  J Physiol       Date:  2008-11-03       Impact factor: 5.182

Review 10.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.